GenScript

71 articles about GenScript

• GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance

  3/26/2024

  GenScript, a global leader in life science research and application services, is excited to announce that it has been awarded the Bronze Medal by the internationally renowned provider of business sustainability ratings EcoVadis.

• GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%

  3/12/2024

  GenScript Biotech Corporation (HK.1548), a world's leading technology and service provider of life science R&D and manufacturing, announced its annual results for the year ended December 31, 2023.

• Dr. David Liu Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy

  3/8/2024

  GenScript is excited to announce that Dr. David R. Liu, a prominent figure in the field of genome editing, has been appointed to the company's scientific advisory board (SAB).

• Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs

  3/6/2024

  GenScript, a leading provider of life science research and application services, proudly announced that Dr. Carl June, a distinguished figure in the field of immunotherapy, has joined the company's scientific advisory board.

• GenScript Biotech Corporation Expands Collaboration with Roche

  3/5/2024

  GenScript Biotech Corporation, a global leader in life science research tools and services, is pleased to announce the expansion of their collaboration with Roche.

• GenScript Announces Its Inaugural Life Science Research Grant Project

  2/5/2024

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, proudly announces the initiation of the GenScript Life Science Research Grant Project.

• San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry

  1/12/2024

  Every January, the global medical health and financial investment sectors turn their focus to San Francisco.

• GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry

  1/4/2024

  On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during the 42nd J.P. Morgan Healthcare Conference in San Francisco, USA.

• GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector

  1/4/2024

  GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech, will be attending the 42nd JPM Healthcare Conference held in San Francisco, California, USA, from January 8 to 11, 2024.

• FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy

  12/25/2023

  The innovative development of biopharmaceuticals has ushered in a new era for disease treatment, bringing unprecedented hope to countless patients.

• Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT

  12/14/2023

  Technological advancements continuously empower the life sciences. Gene and cell therapy, as breakthrough treatments, are turning the once-unreachable dream of curing many diseases into reality.

• CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global Forum

  12/7/2023

  The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination.

• GenScript Named a BioSpace 2024 Best Place to Work

  12/1/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has been named among the Top 30 Large Employers as a BioSpace 2024 Best Place to Work.

• GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation

  9/18/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its IVT mRNA synthesis portfolio with the addition of customized circular RNA and lipid nanoparticles formulation services.

• GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides and APIs

  8/8/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modified peptides at its state-of-the-art cGMP manufacturing facility in Zhenjiang, China.

• GenScript Doubles cGMP sgRNA and Non-Viral DNA Payload Manufacturing Capacity

  7/6/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its cGMP manufacturing capacity for sgRNA and non-viral DNA payloads with a new, state-of-the-art facility in Zhenjiang, Jiangsu, China.

• GenScript Debuts AmMag™ Quatro to Revolutionize Automated Plasmid Maxi-Prep Purification

  6/20/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has added the AmMag™ Quatro automated plasmid purification system to its lab and research product line-up.

• GenScript Debuts GenTitan Gene Fragments Service to Expedite Gene Synthesis at Lower Cost

  5/23/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, announced the debut of its breakthrough GenTitan™ Gene Fragments Synthesis service.

• GenScript to Debut Expanded Synthetic Biology Product Line at SynBioBeta 2023

  5/22/2023

  GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is a sponsor of this year's SynBioBeta Conference in Oakland, California.

• GenScript Expands Peptide and Oligonucleotide Production Facility in China

  5/18/2023

  GenScript's new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity oligonucleotide and peptide synthesis service for R&D and preclinical applications.